Part of Cancer staging guidance sheets
Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
Introduction
This is the data sheet for TNM 9th edition staging of the larynx (ICD10 C32.0 C32.1, C32.2, C10.1)
For more detailed information regarding TNM staging, please see pages 34-38 of the UICC TNM 9 book.
Stage groupings
|
Stage Group |
T stage |
N stage |
M stage |
|---|---|---|---|
|
Stage 0 |
Tis |
N0 |
M0 |
|
Stage I |
T1 |
N0 |
M0 |
|
Stage II |
T2 |
N0 |
M0 |
|
Stage III |
T3 |
N0 |
M0 |
|
|
T1, T2, T3 |
N1 |
M0 |
|
Stage IVA |
T4a |
N0, N1 |
M0 |
|
|
T1, T2, T3, T4a |
N2 |
M0 |
|
Stage IVB |
T4b |
Any N |
M0 |
|
|
Any T |
N3 |
M0 |
|
Stage IVC |
Any T |
Any N |
M1 |
TNM classical classification
T - primary tumour
Supraglottis
|
T value |
Description |
|---|---|
|
cTX |
Primary tumour cannot be assessed |
|
cT0 |
No evidence of primary tumour |
|
cTis |
Carcinoma in situ |
|
cT1 |
Tumour limited to one subsite of supraglottis with normal vocal cord mobility |
|
cT2 |
Tumour invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of piriform sinus) without fixation of the larynx |
|
cT3 |
Tumour limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre‐epiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage |
|
cT4A |
Tumour invades through the thyroid cartilage and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, or oesophagus |
|
cT4b |
Tumour invades prevertebral space, encases carotid artery, or invades mediastinal structures |
Glottis
|
T value |
Description |
|---|---|
|
cTX |
Primary tumour cannot be assessed |
|
cT0 |
No evidence of primary tumour |
|
cTis |
Carcinoma in situ |
|
cT1 |
Tumour limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility T1a - Tumour limited to one vocal cord T1b - Tumour involves both vocal cords |
|
cT2 |
Tumour extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility |
|
cT3 |
Tumour limited to larynx with vocal cord fixation and/or invades paraglottic space, and/or inner cortex of the thyroid cartilage |
|
cT4a |
Tumour invades through the outer cortex of the thyroid cartilage, and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus |
|
cT4b |
Tumour invades prevertebral space, encases carotid artery, or mediastinal structures |
Subglottis
|
T value |
Description |
|---|---|
|
cTX |
Primary tumour cannot be assessed |
|
cT0 |
No evidence of primary tumour |
|
cTis |
Carcinoma in situ |
|
cT1 |
Tumour limited to subglottis |
|
cT2 |
Tumour extends to vocal cord(s) with normal or impaired mobility |
|
cT3 |
Tumour limited to larynx with vocal cord fixation |
|
cT4a |
Tumour invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus |
|
cT4b |
Tumour invades prevertebral space, encases carotid artery, or invades mediastinal structures |
N - regional lymph nodes
|
N value |
Description |
|---|---|
|
cNX |
Regional lymph nodes cannot be assessed |
|
cN0 |
No regional lymph node metastasis |
|
cN1 |
Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension without extranodal extension |
|
cN2 |
Metastasis described as: |
|
|
N2a - Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension without clinical extranodal extension N2b - Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, without clinical extranodal extension N2c - Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension, without clinical extranodal extension |
|
cN3a |
Metastasis in a lymph node more than 6 cm in greatest dimension without extranodal extension |
|
cN3b |
Metastasis in a single or multiple lymph nodes with clinical extranodal extension* |
Note:
* Clinical extranodal extension is defined as the presence of skin involvement or soft tissue invasion with deep fixation to underlying muscle or adjacent anatomical structures or clinical signs of nerve involvement. Imaging is becoming a standard method of detecting unequivocal extranodal extension. Midline nodes are considered ipsilateral nodes.
M - distant metastasis
|
M value |
Description |
|---|---|
|
M0 |
No distant metastasis |
|
M1 |
Distant Metastasis |
TNM pathological classification
pT - primary tumour
The pT categories correspond to the T categories as per above.
pN - regional lymph nodes
Histological examination of a selective neck dissection specimen should ordinarily include six or more lymph nodes. Histological examination of a radical or modified radical neck dissection specimen should ordinarily include 15 or more lymph nodes.
| pN value | Description |
|---|---|
|
pNX |
Regional lymph nodes cannot be assessed |
|
pN0 |
No regional lymph node metastasis |
|
pN1 |
Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension without pathological extranodal extension |
|
pN2 |
Metastasis described as: |
|
|
pN2a - Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension with pathological extranodal extension* OR metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in greatest dimension without pathological extranodal extension pN2b - Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, without pathological extranodal extension pN2c - Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension, without pathological extranodal extension |
|
pN3a |
Metastasis in a lymph node more than 6 cm in greatest dimension without pathological extranodal extension |
|
pN3b |
Metastasis in a single lymph node more than 3 cm in greatest dimension with pathological extranodal extension* OR metastasis in multiple ipsilateral or any contralateral or bilateral node(s) with pathological extranodal extension |
Notes
* Pathological extranodal extension (pENE) should only be diagnosed when tumour that is present within the confines of a lymph node definitively transgresses through the entire thickness of the lymph node capsule into the surrounding connective tissue, with or without stromal reaction. A soft tissue deposit should be considered as at least one lymph node with extranodal extension if it occurs at a site where a regional lymph node would be expected.
Last edited: 16 January 2026 3:15 pm